Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Even H Rustad

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Blood Advances|March 4, 2020
Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myelomaBachisio Ziccheddu, Giulia Biancon, Filippo Bagnoli, et al.
Blood Cancer Journal|February 1, 2020
Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
Blood Cancer Journal|December 13, 2019
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
Cell Reports|January 19, 2023
Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variantsSaskia Meyer, Isaac Blaas, Ravi Chand Bollineni, et al.
Nature Communications|January 13, 2021
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myelomaEileen M Boyle, Shayu Deshpande, Ruslana Tytarenko, et al.
The Journal of Molecular Diagnostics : JMD|November 20, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing: Feasibility, Challenges, and Direct Comparison with High-Sensitivity Flow CytometryCaleb Ho, Mustafa Syed, Mikhail Roshal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2021
Initial Whole-Genome Sequencing of Plasma Cell Neoplasms in First Responders and Recovery Workers Exposed to the World Trade Center Attack of September 11, 2001Francesco Maura, Benjamin Diamond, Kylee H Maclachlan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple MyelomaEileen M Boyle, Patrick Blaney, James H Stoeckle, et al.
Blood Advances|September 11, 2023
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphomaIvana Spasevska, Ankush Sharma, Chloé B Steen, et al.
Nature Communications|April 23, 2020
Timing the initiation of multiple myelomaEven H Rustad, Venkata Yellapantula, Daniel Leongamornlert, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Blood Advances|March 4, 2020
Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myelomaBachisio Ziccheddu, Giulia Biancon, Filippo Bagnoli, et al.
Blood Cancer Journal|February 1, 2020
Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
Blood Cancer Journal|December 13, 2019
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
Cell Reports|January 19, 2023
Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variantsSaskia Meyer, Isaac Blaas, Ravi Chand Bollineni, et al.
Nature Communications|January 13, 2021
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myelomaEileen M Boyle, Shayu Deshpande, Ruslana Tytarenko, et al.
The Journal of Molecular Diagnostics : JMD|November 20, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing: Feasibility, Challenges, and Direct Comparison with High-Sensitivity Flow CytometryCaleb Ho, Mustafa Syed, Mikhail Roshal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2021
Initial Whole-Genome Sequencing of Plasma Cell Neoplasms in First Responders and Recovery Workers Exposed to the World Trade Center Attack of September 11, 2001Francesco Maura, Benjamin Diamond, Kylee H Maclachlan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple MyelomaEileen M Boyle, Patrick Blaney, James H Stoeckle, et al.
Blood Advances|September 11, 2023
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphomaIvana Spasevska, Ankush Sharma, Chloé B Steen, et al.
Nature Communications|April 23, 2020
Timing the initiation of multiple myelomaEven H Rustad, Venkata Yellapantula, Daniel Leongamornlert, et al.
Pageof 3